Placebo-controlled study on the pharmacokinetics, pharmacodynamics, safety and tolerability of concurrent valproate [valproic acid] and bifeprunox administration in subjects with bipolar I disorder

Trial Profile

Placebo-controlled study on the pharmacokinetics, pharmacodynamics, safety and tolerability of concurrent valproate [valproic acid] and bifeprunox administration in subjects with bipolar I disorder

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jan 2015

At a glance

  • Drugs Bifeprunox (Primary) ; Valproic acid
  • Indications Bipolar I disorders
  • Focus Pharmacokinetics
  • Sponsors Solvay Pharmaceuticals
  • Most Recent Events

    • 07 Sep 2007 Status changed from in progress to completed.
    • 31 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top